Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …

Objective To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …

This viewpoint article on a forecast of clinically meaningful changes in the management of
systemic lupus erythematosus (SLE) in the next 10 years is based on a review of the current …

Objective To date, the only study that has assessed the severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2 mRNA) vaccine in systemic lupus erythematosus (SLE) …

Objective To investigate the impact of biologic disease‐modifying antirheumatic drug
(bDMARD) treatment on the prevalence, seroconversion rate, and longevity of the humoral …

Limited data exists on SARS-CoV-2 sustained-response to vaccine in patients with
rheumatic diseases. This study aims to evaluate neutralizing antibodies (nAB) induced by …

anti-rheumatic drugs (DMARDs) is not only associated with suppression of active
inflammation, but also allows the repair of initial joint damage. However, little is known about …

Objectives Impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic on individuals with arthritis has been highlighted whereas data on other …

У пациентов с иммуновоспалительными (аутоиммунными) ревматическими
заболеваниями (ИВРЗ) существует ряд факторов (пожилой возраст …

Objective To identify risk factors for SARS-CoV-2 infection and for severe/critical COVID-19,
and to assess the humoral response after COVID-19 in these patients. Methods Nationwide …